Tata Capital has invested up to USD 10 million in Apex Kidney Care (AKC) in Mumbai to help the chain expand its network of dialysis services across India. The funding is being done through Tata Capital Healthcare Fund-II (TCHF-II). The capital expenditure over the medium term is pegged at Rs 150 crore.

Most of the funds would be used for growth-oriented activities, such as scaling up businesses comprising standalone centres, shop-in-shop aka centres within a hospital or nursing homes, and home dialysis services.

At present, AKC runs six standalone centres and the plan is to take the tally upwards of 60 centres in the medium term. The company runs 61 centres with hospitals and nursing homes and manages 84 centres under the public-private partnership (PPP) model in association with the government and municipal bodies.

The fund takes a holistic approach to investing capital and backs companies which address glaring gaps in healthcare. TCHF has raised nearly USD 200 million across two funds, TCHF-I (2012) and TCHF-II (2022). Across both the funds, TCHF has invested in 16 companies so far.